Skip to search formSkip to main contentSkip to account menu

S 4661

Known as: S-4661 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2005
Highly Cited
2005
ABSTRACT Doripenem 50% inhibitory concentrations (MIC50) and 90% inhibitory concentrations (MIC90) for multidrug-resistant… 
2005
2005
S-4661 is a methylcarbapenem antibiotic newly developed in Japan. We evaluated the combined actions of carbapenems, including S… 
Highly Cited
2004
Highly Cited
2004
The Ministry of Health and Welfare, Japan banned coadministration of carbapenems, such as panipenem/betamipron (PAPM), meropenem… 
Review
2002
Review
2002
Carbapenems are β-lactam antibiotics characterised by the presence of a β-lactam ring with a carbon instead of sulfone in the 4… 
2000
2000
The activity of S-4661, a new parenteral carbapenem antibiotic, was evaluated against 202 recent clinical isolates of respiratory… 
Highly Cited
1998
Highly Cited
1998
ABSTRACT The in vitro and in vivo antibacterial activities of S-4661, a new 1β-methylcarbapenem, were compared with those of… 
Highly Cited
1998
Highly Cited
1998
A new pharmacodynamic model for the analysis of in vitro bactericidal kinetics was developed based on the logistic growth model… 
Highly Cited
1996
Highly Cited
1996
The synthesis and biological activity of (1R,5S,6S)-2-[(3S,5S)-5-substituted pyrrolidin-3-ylthio]-6-[(1R)-1-hydroxyethyl]-1…